Showing the single result

  • Oxnard


    Lupus is a complex autoimmune disorder where the body mistakenly attacks its tissues. This phase 1 clinical trial aims to assess the safety, dosage, and side effects of a novel treatment for SLE in a controlled group, paving the way for effective, targeted therapies.

    Criteria & Qualifications: • More than 18 years.

    Compensation: Contact us for more information

    Read more